English
  1. Home
  2. Stocks
  3. Concordbio Share Price
  • Chart
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Concord Biotech

    Mid Cap
    ₹1,463.5
    +14.15 (0.98%)
    01 June, 2024 05:05 BSE: 543960 NSE: CONCORDBIOISIN: INE338H01029

    Start SIP in Concord Biotech

    Start SIP

    Concord Biotech Performance

    Day Range

    • Low 1,423
    • High 1,489
    ₹ 1,463

    52 Week Range

    • Low 900
    • High 1,725
    ₹ 1,463
    • Open Price1,449
    • Previous Close1,449
    • Volume244318

    Concord Biotech Share Price

    • Over 1 Month -11.33%
    • Over 3 Month -0.55%
    • Over 6 Month +13.82%
    • Over 1 Year +97.5%

    Concord Biotech Key Statistics

    P/E Ratio 49.7
    PEG Ratio 1.8
    Market Cap Cr 15,311
    Price to Book Ratio 10
    EPS 29.1
    Dividend 0
    Relative Strength Index 45.33
    Money Flow Index 22.68
    MACD Signal -25.65
    Average True Range 60
    Concord Biotech Financials
    IndicatorMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 319241262195273
    Operating Expenses Qtr Cr 185135143123144
    Operating Profit Qtr Cr 13410611972129
    Depreciation Qtr Cr 1414131314
    Interest Qtr Cr 00111
    Tax Qtr Cr 3426291732
    Net Profit Qtr Cr 9775844894
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 1,051888
    Operating Expenses Annual Cr 585510
    Operating Profit Annual in Cr 432343
    Depreciation Cr 5454
    Interest Annual Cr 35
    Tax Annual Cr 10482
    Net Profit Annual Cr 305238
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 265246
    Cash from Investing Activity Annual Cr -155-158
    Cash from Financing Annual Activity Cr -99-85
    Net Cash Flow Annual Cr 3
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 1,5251,292
    Fixed Assets Annual Cr 787766
    Total Non Current Assets Annual Cr 803787
    Total Current Assets Annual Cr 896728
    Total Assets Annual Cr 1,6991,515
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 146123
    ROE Annual % 2018
    ROCE Annual % 2625
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 4644
    IndicatorMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 319241262195273
    Operating Expenses Qtr Cr 185135143123144
    Operating Profit Qtr Cr 13410611972129
    Depreciation Qtr Cr 1414131314
    Interest Qtr Cr 00111
    Tax Qtr Cr 3426291732
    Net Profit Qtr Cr 9578815491
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 1,051888
    Operating Expenses Annual Cr 585510
    Operating Profit Annual in Cr 432343
    Depreciation Cr 5454
    Interest Annual Cr 35
    Tax Annual Cr 10482
    Net Profit Annual Cr 308240
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 265246
    Cash from Investing Activity Annual Cr -155-158
    Cash from Financing Annual Activity Cr -99-85
    Net Cash Flow Annual Cr 123
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 1,5271,290
    Fixed Assets Annual Cr 787766
    Total Non Current Assets Annual Cr 804786
    Total Current Assets Annual Cr 896728
    Total Assets Annual Cr 1,7011,514
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 146123
    ROE Annual % 2019
    ROCE Annual % 2625
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 4644
    Invest in Concord Biotech

    Concord Biotech Technicals

    EMA & SMA

    Current Price
    ₹1,463.5
    +14.15 (0.98%)
    pointer
    • Bullish Moving Average
    • ___
    • 7
    • Bearish Moving Average
    • ___
    • 7
    • 20 Day
    • ₹1,479.42
    • 50 Day
    • ₹1,496.57
    • 100 Day
    • ₹1,452.00
    • 200 Day
    • ₹
    • 20 Day
    • ₹1,480.02
    • 50 Day
    • ₹1,521.66
    • 100 Day
    • ₹1,482.45
    • 200 Day
    • ₹

    Concord Biotech Resistance and Support

    PIVOT
    ₹1,458.6
    Resistance
    First Resistance 1,493.90
    Second Resistance 1,524.30
    Third Resistance 1,559.60
    RSI 45.33
    MFI 22.68
    MACD Single Line -25.65
    MACD -27.97
    Support
    First Support 1,428.20
    Second Support 1,392.90
    Third Supoort 1,362.50

    Concord Biotech Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 252,095 14,064,380 55.79
    Week 1,400,560 82,927,169 59.21
    1 Month 360,290 21,159,842 58.73
    6 Month 178,546 9,429,019 52.81

    Concord Biotech Result Highlights

    Concord Biotech Synopsis

    NSE-Medical-Biomed/Biotech

    Concord Biotech Ltd. is involved in the business activities of Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 853.17 Cr. and Equity Capital is Rs. 10.46 Cr. for the Year ended 31/03/2023. Concord Biotech Ltd. is a Public Limited Listed company incorporated on 23/11/1984 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is U24230GJ1984PLC007440 and registration number is 007440.
    Market Cap 15,311
    Sales 1,017
    Shares in Float 5.86
    No of funds 91
    Yield
    Book Value 9.95
    U/D Vol ratio 0.5
    LTDebt / Equity
    Alpha 0.19
    Beta 0.63

    Concord Biotech Shareholding Pattern

    Owner NameMar-24Dec-23Sep-23
    Promoters 44.08%44.08%44.08%
    Mutual Funds 5.15%5.65%5.58%
    Insurance Companies 2.88%2.47%2.26%
    Foreign Portfolio Investors 6.49%7%7.3%
    Individual Investors 7.08%6.76%6.78%
    Others 34.32%34.04%34%

    Concord Biotech Management

    Name Designation
    Mr. Sudhir Vaid Chairman & Managing Director
    Mr. Ankur Vaid Joint Managing Director & CEO
    Mr. Ravi Kapoor Non Executive Director
    Mr. Rajiv Ambrish Agarwal Non Exe. & Nominee Director
    Mr. Utpal Sheth Non Exe. & Nominee Director
    Mr. Amit Varma Non Exe. & Nominee Director
    Ms. Bharti Khanna Independent Director
    Mr. Anil Katyal Independent Director
    Mr. Amitabh Thakore Independent Director
    Mr. Arvind Agarwal Independent Director
    Mr. Jayaram Easwaran Independent Director
    Mr. Mandayam Chakravarthy Sriraman Independent Director

    Concord Biotech Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Concord Biotech Corporate Action

    Date Purpose Remarks
    2024-05-23 Audited Results & Dividend
    2024-02-08 Quarterly Results
    2023-11-08 Quarterly Results
    Date Purpose Remarks
    2024-06-22 FINAL Rs.8.75 per share(875%)Dividend

    Concord Biotech MF Shareholding

    Name Amount(cr)
    HSBC Small Cap Fund Fund Regular Growth 14,619
    Franklin India Smaller Companies Fund Growth 12,587
    Nippon India Pharma Fund - Growth 7,133
    Edelweiss Mid Cap Fund Growth 5,534
    Union Small Cap Fund Regular Growth 3,965

    Concord Biotech FAQs

    What is Share Price of Concord Biotech ?

    Concord Biotech share price is ₹1,463 As on 01 June, 2024 | 04:51

    What is the Market Cap of Concord Biotech ?

    The Market Cap of Concord Biotech is ₹15310.6 Cr As on 01 June, 2024 | 04:51

    What is the P/E ratio of Concord Biotech ?

    The P/E ratio of Concord Biotech is 49.7 As on 01 June, 2024 | 04:51

    What is the PB ratio of Concord Biotech ?

    The PB ratio of Concord Biotech is 10 As on 01 June, 2024 | 04:51

    Q2FY23
    Open Free Demat Account

    Be a part of 5paisa community - The first listed discount broker of India.

    +91
     

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.